Lbp Am Sa Raises Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

LBP AM SA increased its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 45.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 54,034 shares of the company's stock after buying an additional 16,856 shares during the quarter. LBP AM SA's holdings in Cardinal Health were worth $6,391,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Frazier Financial Advisors LLC boosted its position in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after purchasing an additional 104 shares during the last quarter. Promus Capital LLC purchased a new position in Cardinal Health in the fourth quarter worth about $30,000. AM Squared Ltd purchased a new position in Cardinal Health in the third quarter worth about $33,000. Kentucky Trust Co purchased a new position in Cardinal Health in the fourth quarter worth about $41,000. Finally, HHM Wealth Advisors LLC lifted its position in shares of Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after buying an additional 144 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

NYSE:CAH traded up $0.63 during trading hours on Wednesday, reaching $132.09. The stock had a trading volume of 1,364,395 shares, compared to its average volume of 1,967,222. The stock has a market capitalization of $31.91 billion, a PE ratio of 24.64, a PEG ratio of 1.49 and a beta of 0.66. The company has a 50 day moving average price of $126.75 and a two-hundred day moving average price of $119.69. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $133.12.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is currently 37.69%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CAH. Evercore ISI raised Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective on the stock in a research report on Tuesday, January 7th. Wells Fargo & Company lifted their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Argus set a $148.00 price objective on Cardinal Health in a research report on Tuesday, February 4th. Mizuho began coverage on Cardinal Health in a research report on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price objective on the stock. Finally, JPMorgan Chase & Co. lifted their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average price target of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.